Evidence map›Paper›PMID 34899339›Full record

ArticleFrontiers in pharmacology2021

Zhi-Hao Zhang, Juan Li, Jun Li, Zhaowu Ma, Xian-Ju Huang

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pharmacology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Therapeutic Potential ofBiomedicines · 2025
    Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Zhi-Hao ZhangCollege of Pharmacy, South-Central University for Nationalities, Wuhan, China.
Juan LiKey Laboratory of Environmental Health, Ministry of Education, Department of Toxicology, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Jun LiCollege of Pharmacy, South-Central University for Nationalities, Wuhan, China.
Zhaowu MaSchool of Basic Medicine, Health Science Center, Yangtze University, Jingzhou, China.
Xian-Ju HuangCollege of Pharmacy, South-Central University for Nationalities, Wuhan, China.
South Central University for Nationalities · CNHuazhong University of Science and Technology · CNYangtze University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Type 2 diabetes mellitus (T2DM) is a complex and polygenic disorder with diverse complications.

Indexed as

diabetes mellitusdiabetic liver injuryinsulin resistancetranscriptomeVeratrilla baillonii franch

Identifiers

PMID34899339
PMCPMC8662784
OpenAlexW3214821327

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.